Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Showing 16 of 0 results

Large-scale testing (Phase 3)Study completedNCT00560755
What this trial is testing

Safety Study of ProQuad® rHA in Infants (V221-037)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 3,388
Testing effectiveness (Phase 2)Ended earlyNCT00634933
What this trial is testing

Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 222
Testing effectiveness (Phase 2)Study completedNCT02824198
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 118
Testing effectiveness (Phase 2)Study completedNCT03486834
What this trial is testing

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Who this might be right for
Cytomegalovirus (CMV) Infections
Merck Sharp & Dohme LLC 2,200
Testing effectiveness (Phase 2)UnknownNCT00022321
What this trial is testing

Gemtuzumab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00479999
What this trial is testing

Phase 1 Safety Study of Two Experimental HIV Vaccines

Who this might be right for
AIDS VaccinesHIV InfectionsHIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 35
Large-scale testing (Phase 3)Study completedNCT04476511
What this trial is testing

The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules

Who this might be right for
Vitamin D Deficiency
Semmelweis University 75
Early research (Phase 1)Study completedNCT01702857
What this trial is testing

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)

Who this might be right for
Dengue Fever
U.S. Army Medical Research and Development Command 100
Testing effectiveness (Phase 2)Study completedNCT01650870
What this trial is testing

Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults

Who this might be right for
Colonoscopy
Benaroya Research Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT02418754
What this trial is testing

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 505
Early research (Phase 1)Study completedNCT02500953
What this trial is testing

A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects

Who this might be right for
Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects
Astellas Pharma Inc 124
Large-scale testing (Phase 3)Looking for participantsNCT07348692
What this trial is testing

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Who this might be right for
Pneumococcal ImmunizationHealthy Volunteers
Sanofi 2,195
Early research (Phase 1)Study completedNCT01335256
What this trial is testing

Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced Malignancies

Who this might be right for
Neoplasms
Bayer 10
Testing effectiveness (Phase 2)Study completedNCT00332956
What this trial is testing

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Who this might be right for
Healthy Volunteers
DynPort Vaccine Company LLC, A GDIT Company 400
Large-scale testing (Phase 3)Study completedNCT00111137
What this trial is testing

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

Who this might be right for
CancerNon-Myeloid Malignancies
Amgen 718
Testing effectiveness (Phase 2)Study completedNCT00134719
What this trial is testing

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 1,104

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation